Physician

Adrian Subrt, MD

According to 2025 Medicare claims, Adrian Subrt, MD (NPI: 1386055382) practices dermatology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Harris, TX. This provider's primary affiliated billing organization is WESTSIDE DERMATOLOGY CLINIC , PA. (NPI: 1629115316; TIN: 200397117) and primary practice location at 77493-2737.

Subrt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 889 traditional Medicare patients, billed 1,957 HCPCS/CPT codes, and received $123,351 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 2,063 prescription claims across 787 beneficiaries totaling $360,409 in drug costs, led by Taltz Autoinjector (Ixekizumab). Open Payments data shows 67 records totaling $1,168. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $8,500 to $360,409. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$66K$132K2018 Medicare payment: $17,220 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $90,124 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $131,920 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $121,545 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $112,011 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $113,150 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $123,351 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018170263$17,220
20198231,547$90,124
20209612,137$131,920
20218241,832$121,545
20228211,757$112,011
20238541,803$113,150
20248891,957$123,351

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$218K$436K2015 Drug cost: $8,500 (USD; Tot_Drug_Cst)2016 Drug cost: $22,865 (USD; Tot_Drug_Cst)2017 Drug cost: $18,217 (USD; Tot_Drug_Cst)2018 Drug cost: $33,727 (USD; Tot_Drug_Cst)2019 Drug cost: $138,804 (USD; Tot_Drug_Cst)2020 Drug cost: $287,506 (USD; Tot_Drug_Cst)2021 Drug cost: $293,206 (USD; Tot_Drug_Cst)2022 Drug cost: $435,539 (USD; Tot_Drug_Cst)2023 Drug cost: $349,479 (USD; Tot_Drug_Cst)2024 Drug cost: $360,409 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201579148$8,500
2016178362$22,865
2017103204$18,217
2018163311$33,727
20194721,180$138,804
20205761,457$287,506
20216931,853$293,206
20227001,777$435,539
20237231,865$349,479
20247872,063$360,409

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths288334$80
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more150150$65
11102Biopsy of related skin growth, first growth6466$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more634813$57
17000Destruction of precancer skin growth, 1 growth227256$44

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Taltz AutoinjectorIxekizumab11308$72,117
Dupixent PenDupilumab13364$49,675
Clobetasol PropionateClobetasol Propionate2637,804$10,599
MetronidazoleMetronidazole732,069$7,142
FluocinonideFluocinonide1564,372$6,222

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.67$1,168ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adrian Subrt, MD?

Tedicare shows public-source Medicare data for Adrian Subrt, MD (NPI 1386055382), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adrian Subrt, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adrian Subrt, MD?

Adrian Subrt, MD is linked to WESTSIDE DERMATOLOGY CLINIC , PA. (billing NPI 1629115316) in the available physician profile data.

Does Adrian Subrt, MD have Open Payments data?

Adrian Subrt, MD has 67 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.